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EDITORIAL COMMENT
Carotid Sinus Massage in
Patients Who Fall: Will It
Define the Role of Pacing?*
John H. McAnulty, MD
Portland, Oregon
In this era of diagnostic and therapeutic glitz, can a simple,
safe, and universally applicable clinical maneuver—carotid
sinus massage—favorably affect a clinical outcome in a large
number of patients? Possibly.
In this issue of the Journal, Kenny et al. (1) have evaluated
patients presenting to an emergency room because of an
unexplained fall. In a prospective randomized study they
assessed the effect of permanent pacing in individuals who
had experienced nonaccidental falls and who had a positive
cardioinhibitory response (a 3-s pause) to carotid sinus
massage. Insertion of a dual-chamber pacemaker with
rate-drop programming resulted in a 70% reduction in the
number of subsequent falls compared to nonpaced controls
and a 50% reduction in syncope. Given the consequences of
falls in the elderly as reviewed by the investigators—injuries
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in 10% to 20% of cases and the sixth leading cause of
death—and given their frequency—occurring in 30% to
60% of those over age 65—the potential impact of this
combination of a universally applicable maneuver and avail-
able treatment (at least in the U.S.) may be significant. The
investigators never imply that falls are simple, and they em-
phasize the potential multifaceted etiology, but the study
results imply a significant contribution from bradyarrhythmias.
The problem—falls—is so major, the diagnostic proce-
dure so easy, the treatment so readily available and the study
so good that it is tempting to proceed with pacemaker
insertion. However, there are many soft aspects to this
study. Some relate to methodology. Although the study was
prospective and randomized, timing of randomization in
relation to the index event is not clear, and pacemakers were
not inserted until several weeks after the presumed time of
randomization. Additionally, management of associated fall-
related variables such as gait disturbances or other medical
problems is not addressed and not controlled. The definition of
falls is reasonable but leaves room for marked variation in
interpretation. Carotid massage resulted in a 3-s pause in 15%
of those in whom it was performed. Thus, the majority of
patients with nonaccidental falls are not likely to benefit from
pacing (or at least were not evaluated in this study). Follow-up
was from diary entry. Although the diary return rate was
excellent, there are limitations with that approach—a particular
problem when considering the issue of amnesia related to falls
associated with loss of consciousness that is addressed by the
investigators. Moreover, the number of patients in the study is
too small to assess the impact on incidence of fractures and
mortality (a subject addressed in other studies).
The study by Kenny et al. (1) raises many questions—this
can be considered a strength. Are there subgroups in this huge
population who can more clearly benefit from pacing? The
investigators were very restrictive in regards to trial eligibility;
42% of patients were ineligible because of presumed medical
explanations or because of poor performance on a mini-mental
status exam. Although reasonable for this study, it is possible
that they too can be helped with pacing, adding to the
intriguing aspects of this work. Would a 2-s pause, rather than
the 3-s pause required for this study, have allowed more
participants to benefit from pacing? Can other pacing modal-
ities be just as effective? The value of the more complex, more
expensive dual-chamber (as compared to single-chamber) pac-
ing is questioned by recent reports from two large prospective
trials (2,3). Perhaps a unit less complex than the two-chamber
devices used in the Kenny et al. (1) study could achieve the
same results. What are the cost implications? Is the simple
“cost-less” maneuver of carotid massage only opening the door
to expensive treatment or does it significantly decrease the cost
of evaluation and treatment of subsequent falls?
Overall, the Kenny et al. (1) investigation is a landmark
study. Still, the limitations are too great to comfortably
apply this approach to the huge number of elderly patients
presenting with falls. It should serve as a strong stimulus to
future research on the subject. As research continues, it also
offers an opportunity for clinician scientists to work with
pacemaker manufacturers in assessing smaller and more
simple, less expensive devices that might adequately achieve
the same goals in this population.
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